๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparison of methods of evaluating nephrotoxicity of cis-platinum

โœ Scribed by Jones, Brian R; Bhalla, Ravi B; Mladek, Jiri; Kaleya, Ronald N; Gralla, Richard J; Alcock, Nancy W; Schwartz, Morton K; Young, Charles W; Reidenberg, Marcus M


Book ID
109843008
Publisher
Nature Publishing Group
Year
1980
Tongue
English
Weight
428 KB
Volume
27
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Control of some aspects of cis-platinum
โœ Mark M. Jones; Mark A. Basinger; Warren D. Craft; Jose L. Domingo; Juan M. Llobe ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 479 KB

The elevations of blood urea nitrogen and serum creatinine caused by cis-platinum in rats can be prevented by a combination of procedures centered around the administration of sodium N-methyl-N-dithiocarboxyglucamine (NaG), before and very soon after the cis-platinum is administered in hypertonic (4

Control of nephrotoxicity in the rat dur
โœ Mark M. Jones; Mark A. Basinger ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 472 KB ๐Ÿ‘ 1 views

The nephrotoxicity of cis-platinum (CDDP) in the rat can be controlled throughout a series of weekly administrations of CDDP (each of 5 mg kg-', i.v.) for at least three weeks by a combination of protective measures involving pretreatment with dithiocarbamates and diuretics and the administration of

Comparison of three methods of evaluatin
โœ Claes Beckman; Rolene Scott; Leon F. Garner ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Wiley (Blackwell Publishing) ๐ŸŒ English โš– 513 KB
Nephrotoxicity of cis-diamminedichloride
โœ S. Meijer; N. H. Mulder; D. Th. Sleijfer; P. E. Jong; W. J. Sluiter; H. Schraffo ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 290 KB

We studied renal function in nine patients with disseminated testicular carcinoma before and after remission-induction and maintenance therapy with a drug combination containing cis-platinum. The median glomerular filtration rate (GFR) decreased during remission-induction therapy from 146 to 118 ml/